Health● Low2h ago · Nov 4, 2026, 12:27 AM
Madrigal anticipates late 2027 MAESTRO-NASH OUTCOMES readout while planning 2,000+ patient MAESTRO-CSPH study
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Madrigal Pharmaceuticals expects late 2027 results from its MAESTRO-NASH OUTCOMES study and is planning a large MAESTRO-CSPH study with over 2,000 patients. This provides an update on the company's clinical development pipeline.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Health
Not flagged as developing.
More in Health
Health1h agoBarbados Meets WHO Goal to End HIV Transmission to BabiesHuman ProgressHealth1h agoUS Approval May Speed HIV Prevention in Poor CountriesHuman ProgressHealth3h agoAbia: How one woman ended Okuenyi mothers’ dangerous trek for childbirthVanguard NigeriaHealth6h agoKerala Sasthra Sahithya Parishad seeks reconstitution of government’s health task forceThe Hindu